Subscribe

The Future Of Regenerative Medicine

The guest for the 30th episode of Ayık Kafa is Dr. Adeel Khan, an Interventional Cell and Gene Therapy Specialist who is the CEO and Founder of Eterna Health Clinics. Dr. Khan is a cell and gene therapy specialist with a visionary approach that is changing the way we perceive healthcare worldwide. Khan has cemented his reputation as a regenerative medicine expert and a driven entrepreneur.

Share this podcast

In this Episode of Ayık Kafa

The discussion covers the initial excitement and skepticism around stem cell therapy. Recent advancements have led to better standardization and programming of stem cells, significantly improving their ability to regrow and repair tissues. MUSE cells are highlighted for their superior stress endurance and pluripotency, making them particularly effective in regenerative treatments.

00:00-3:36 Introduction
3:36-5:28 Overview of the goals and potential of regenerative medicine.
5:28-13:36 Recent advancements in stem cell therapy, better standardization of treatments.
13:36-20:56 MUSE Cells and their advantages in regenerative treatments.
19:57-24:56 Dr. Khan’s vision of regenerative medicine.
24:56-28:11 Potential and innovations in gene therapy.
28:11-33:21 Follistatin Gene Therapy, its benefits for muscle strength, and longevity.
33:21-40:18 GHK copper peptide, Clotho gene and Exosomes.
40:18-46:48Dr. Khan’s comprehensive approach with his patients.
46:48-52:15 The innovative use of vagus nerve injections to treat conditions like PTSD.
52:15-55:18 Conclusion

Adeel Khan
Website: www.eterna.health
Instagram: @dr.akhan

Disclaimer
The information and statements on our website are not intended to guide individuals towards medical diagnosis and treatment. Please consult with your doctor for medical diagnostic and treatment procedures. The contents are shared for informational purposes only, derived from scientific studies prepared by EMC Medya Yayıncılık Ticaret Ltd. Şti.’s researchers, consultants, and authors/scientists, as well as compilations from publicly available publications. Our texts do not contain health statements related to medical diagnosis or treatment

Subscribe to Longevilab​

Subscribe to our newsletter and stay updated.

Subscribe to Longevilab​

Subscribe to our newsletter and stay updated.

*